by Mould and Upton. Code is provided for several examples in a format for the widely used R data analysis and statistical language [1] . This can be saved by cutting and pasting into a text-editor (preferably with syntax highlighting for R) and then executing in R. No additional R packages are required for the supplied code.
Please note that these models are not the best possible model for the supplied data, but are intended to demonstrate the principles of coding the models. The example data should be cut and pasted into a spreadsheet program and saved as a comma separated file with the name indicated. The control streams can be cut and pasted into a text editor then saved into the same folder as the data file for executing the NONMEM run. Models were developed using NONMEM Version 7 level 2.0. Wings for NONMEM Version 720 [3] was used a "front end" for the NONMEM program.
Concept of Censoring Due to the LLOQ
In a key paper [4] , Beal discussed 7 potential methods for the population pharmacokinetic modeling of data with BLQ observations. These included: Method 1 (M1): Not including the BLQ observations (implemented as MDV=1 in NONMEM). Method 2 (M2): Weighting the likelihood of model predicted concentrations that are not BLQ with the probability that they are above the LLOQ (YLO in NONMEM). Method 3 (M3):
Including the probability that the model predicted concentrations for BLQ observations are below the LLOQ as part of the maximum likelihood estimation (F_FLAG in NONMEM).
The effect of LLOQ censoring and the contribution of the M3 method are illustrated in using a simulated data set as shown in Figure 1 . It can be seen that the M3 method was not needed when there was extensive data from higher doses (200 & 50 ug doses, all LLOQ values) that produced full time-courses of uncensored data for some subjects. The M3 method was able to correct for censored data when censoring was present and some subjects had partial data (50 µg dose only and LLOQ = 0.05). The M3 method was not able to correct for censoring when data informing a second compartment were completely missing (50 µg dose only and LLOQ = 0.1). The M3 and YLO methods may have penalties with respect to model run-time and stability that may preclude their use in some circumstances. Note also that the M3 and YLO methods are for estimation, not simulation.
Figure 1 -The effect of censoring due to LLOQ
A data set was simulated for a study where fentanyl was given in 2 doses (50 and 200 ug) via two routes (i.v. and s.c.) to 20 subjects (5 per group) [6, 6] . A two compartment model with (population predictions, black line) and without (population predictions, red line) the M3 method for censored data was fitted to simulated data where the LLOQ was set at 3 different concentrations (0, 0.05 and 0.1 ng/ml) as described above. Furthermore, models were fitted to the data for all doses and routes subjects (20 subjects, upper row) and to data for the 50 µg s.c. doses (5 subjects, lower row). As the lowest observed concentrations were for the 50 µg s.c. cohort, the data for this cohort were most affected by censoring and the fitted results are shown only for this cohort.
The upper row shows a scenario where there higher doses without censoring can inform the model even with substantial censoring of the lower dose data. In this case, models using M1 provided similar fits to models using M3 regardless of the LLOQ value. The lower row shows a scenario where the higher dose data were not used for model building.
When the LLOQ was 0.05, the M3 method was able to provide a similar fit than that for the uncensored data, whereas not using M3 introduced a bias into the fit. When the LLOQ was 0.1, the M3 method was not able to "rescue" the situation, as all subjects were missing the data informing the second compartment of the model. 
12.2

Concepts of Marginal Maximum Likelihood
The concepts of a marginal maximum likelihood can be illustrated graphically by considering one subject from a study population. Figure 2 shows an example for a 1 compartment, first order absorption pharmacokinetic model (100% bioavailability).
Clearance (CL) was log-normally distributed (CL = CL pop *exp(ETA)) and was the only #USING R CODE TO EXPLORE LIKELIHOOD BASED OBJECTIVE FUNCTIONS #See for www.r-project.org for more information about R 
#Using the dnorm function to calculate distribution densities for a point on a normal distribution #For a normal distribution with mean =2 and standard deviation of 1 #2 has the highest distribution density value -it's in the center of the normal distribution density<-dnorm(2, mean=2, sd=1) density #1 is less likely to be in the distribution, it's to the left of the mean density<-dnorm(1, mean=2, sd=1) density #-1 is even less likely, it's further to the left of the mean density<-dnorm(-1, mean=2, sd=1) density #3 is less likely to be in the distribution, it's to the right of the mean density<-dnorm(3, mean=2, sd=1) density #5 is even less likely, it's further to the right of the mean density<-dnorm(5, mean=2, sd=1) density #dnorm does return a normal distribution! x <-seq(from=-1, to=5, by=0.1) densities<-dnorm(x, mean=2, sd=1) plot(densities ~ x, type="l")
#Estimated parameters are CL, V, KA and SIGMA dose<-100 CL <-2 V <-10 KA <-0.5 #Model predicted concentrations given these parameter values Chat <-dose/V*(KA/(KA-CL/V))*(exp(-CL/V*time)-exp(-KA*time)) plot(Cobs ~ time) points(Chat ~ time, type="l") #Calculate likelihood #Proportional residual error of 10% SIGMA <-Chat*0.10 #The log of the distribution density values for Cobs for a distribution with mean Chat and standard deviation of SIGMA densities <-dnorm(Cobs,mean=Chat,sd=SIGMA,log=T) #Calculate the negative loglikelihood for all data points by summing in the log domain (multiplication of likelihoods) negloglike<--1*sum(densities) #Objective function value for this observed data and these parameters #Optimisation is used to find the parameters and sigma that give the lowest OFV OFV <-negloglike OFV #Other subjects are also include in this summation (not shown here) negloglike<--1*sum(densitiesSigma,densitiesOmega) #Objective function value for this observed data and these parameters #Optimisation is used to find the parameters omega and sigma that give the lowest OFV OFV <-negloglike OFV #Objective function value for this observed data and these parameters #Optimisation is used to find the parameters that give the lowest OFV OFV <-negloglike OFV 
12.4
The relationship between rate constants, volumes and clearance and half-lives
The equations for the three compartment model are taken from [9] .
#Equations to convert between rate constants, volumes and clearances and half-lives for 1, 2 and 3 compartment mammillary pharmacokinetic models
#Rate constant parameterization k10 <-CL/V V <-V #Half-life thalf<-log(2)/k10 #natural logarithm
#-------------------------------------------------------------------
#Two compartment model #Hydraulic parameterization CL <-2 V1 <-10 Q <-0.5 V2 <-30 #Rate constant parameterization k10 <-CL/V1 k12 <-Q/V1 k21 <-k12*V1/V2
#Half-lives beta<-0.5*(k12+k21+k10-sqrt((k12+k21+k10)^2-4*k21*k10)) alpha<-k21*k10/beta thalf_alpha<-log(2)/alpha thalf_beta<-log(2)/beta
#Rate constant parameterization k10 <-CL/V1 k12 <-Q12/V1 k21 <-k12*V1/V2 k13 <-Q13/V1 k31 <-k13*V1/V3
#Half-lives j <-k12+k10+k21+k31+k13 k <-k12*k31+k10*k21+k10*k31+k21*k31+k13*k21 l <-k10*k21*k31 m <-(3*k -j^2)/3 n <-(2*j^3 -9*j*k + 27*l)/27 Q <-(n^2)/4 + (m^3)/27
alpha<-sqrt(-1*Q) beta<--1*n/2 rho<-sqrt(beta^2+alpha^2) theta<-atan2(alpha,beta) lambda1 <-j/3 + rho^(1/3)*(cos(theta/3) + sqrt(3)*sin(theta/3)) lambda2 <-j/3 + rho^(1/3)*(cos(theta/3) -sqrt(3)*sin(theta/3)) lambda3 <-j/3 -(2*rho^(1/3)*cos(theta/3)) thalf_alpha<-log(2)/lambda1 thalf_beta<-log(2)/lambda2 thalf_gamma<-log(2)/lambda3
Compartmental models as hydraulic analogues
Visualizing compartmental models as hydraulic analogues can be a useful conceptual tool. Distribution volumes can be represented as tanks; the bigger the distribution volume, the bigger the tank. Drug concentration in a tank is represented by the height of water in a tank. A dose is represented by adding water to the "central" tank. An intravenous infusion may be considered a constant flow of water coming out of a tap; conversely a bolus is quickly adding a fixed volume of water to the tank. Elimination is represented by a tap at the bottom of the tank, with the size of the tap representing the magnitude of clearance. Elimination is first order, as the more water there is in the tank, the faster it will flow out of the "clearance" tap. Inter-compartmental clearance is represented by flow through pipes connecting the bottom of two tanks. The flow rate through the pipe representing the magnitude of the inter-compartmental clearance; increasing the diameter of the pipe increases the compartmental clearance.
The two hydraulic analogues below are a simplified illustration of the key kinetic differences between the opioids alfentanil and fentanyl. The latter has a deep, slowly equilibrating peripheral compartment that can lead to prolonged recovery from long intravenous infusions, as the decline in the post-infusion central compartment concentrations have a significant contribution from the "emptying" of the peripheral compartment in addition to clearance.
12.6
Example NONMEM Code for some Absorption Models 
Data for extravascular dose only examples
